-+ 0.00%
-+ 0.00%
-+ 0.00%

Great News: Wall Street Is Turning Bullish on This Troubled Telehealth Stock

The Motley Fool·06/05/2026 13:05:00
Listen to the news

Hims & Hers Health (NYSE: HIMS) is trying to turn GLP-1 demand, subscriber growth, and international expansion into a much larger healthcare platform. The stock has dropped sharply, margins are under pressure, and valuation still looks demanding, but the long-term upside could become more compelling if Hims proves it can cross-sell into higher-margin care categories.

Stock prices used were the market prices of May 28, 2026. The video was published on June 4, 2026.

Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue »

Rick Orford has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Hims & Hers Health. The Motley Fool has a disclosure policy. Rick Orford is an affiliate of The Motley Fool and may be compensated for promoting its services. If you choose to subscribe through their link, they will earn some extra money that supports their channel. Their opinions remain their own and are unaffected by The Motley Fool.